European Notebook: IPO Fever Comes To Europe; EMA Plans Adaptive Licensing Pilot Project
Executive Summary
Pharmaceutical and biotech companies in Europe take heart from IPOs and new governmental schemes to improve patients’ early access to innovative medicines, while fresh calls are made for an integrated, over-arching European industrial strategy for the life sciences sector.